Home

Kenneth T. Mills, President and CEO: Regenxbio RGNX Sell · Filed 23/12/21

Trade details

Type
Insider sale
Amount
$886,050
Shares · price
45,000 sh · $19.69 a share
Held after
355,289 sh
Trade date
23/12/19
Filed
23/12/21
Days to filing
2 days

Sold 11.2% of holdings

Share of holding sold
11.2%

Regenxbio trades, last 26 weeks

What else happened in Regenxbio around then

Filed or reported within 30 days of the trade day · 23/11/19~24/01/18

Kenneth T. Mills's recent trades

  • Kenneth T. Mills

    Sell10b5-1 planRegenxbio

    $163K

    Filed 25/05/14

  • Kenneth T. Mills

    Planned sale10b5-1 planRegenxbio

    $154.9K

    Filed 25/05/12

  • Kenneth T. Mills

    Sell10b5-1 planRegenxbio

    $214.6K

    Filed 24/07/26

  • Kenneth T. Mills

    Sell10b5-1 planRegenxbio

    $168.4K

    Filed 24/07/26

  • Kenneth T. Mills

    Sell10b5-1 planRegenxbio

    $30.4K

    Filed 24/07/18

Kenneth T. Mills, CEO — sold $886K of Regenxbio RGNX · 11.2% of holdings · 10b5-1 plan | Whalegun